GASTROINTESTINAL EPITHELIAL CANCER

Clinical trials for GASTROINTESTINAL EPITHELIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTROINTESTINAL EPITHELIAL CANCER trials appear

Sign up with your email to follow new studies for GASTROINTESTINAL EPITHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists use CRISPR to supercharge immune cells against tough cancers

Disease control Completed

This early-phase trial tested a new cell therapy for people with advanced gastrointestinal cancers that had stopped responding to standard treatments. Researchers collected a patient's own immune cells from a tumor, used CRISPR gene editing to remove a molecular 'brake' (CISH), a…

Matched conditions: GASTROINTESTINAL EPITHELIAL CANCER

Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

GASTROINTESTINAL EPITHELIAL CANCER

Get alerted when new GASTROINTESTINAL EPITHELIAL CANCER trials appear

Scientists use CRISPR to supercharge immune cells against tough cancers